Hospital
Hillside Hospital LLC
Hillside Hospital LLC was paid $3.87M by Medicaid between Jan 2018 and Dec 2024, across 70 billing codes. Its largest line is 99283, emergency room visit (moderate) — 30% of everything it billed.
33Billing provider infoHILLSIDE HOSPITAL LLC
PULASKI, TN 38478
PULASKI, TN 38478
33aNPI1841388519assigned 10/10/2006
33bProvider typeSubstance Use Disorder Rehabilitation Hospital Unit
28Total paid$3.87M
24GClaims97,610
24DCodes billed70
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,405 | $719K | |
| 2019 | 15,295 | $644K | |
| 2020 | 9,151 | $331K | |
| 2021 | 12,790 | $472K | |
| 2022 | 14,430 | $573K | |
| 2023 | 17,094 | $646K | |
| 2024incomplete | 10,445 | $484K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 30% | 13,518 | 11,919 | $1.16M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 10,828 | 9,202 | $1.04M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 7.0% | 4,250 | 3,608 | $270K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.6% | 2,225 | 1,783 | $255K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.0% | 1,771 | 1,486 | $157K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.2% | 3,217 | 891 | $125K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.2% | 2,995 | 2,332 | $125K |
| G0378 | Hospital observation service, per hour | 2.2% | 382 | 287 | $85K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 14,310 | 11,700 | $75K |
| 71045 | Radiologic examination, chest; single view | 1.7% | 2,335 | 1,901 | $65K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.7% | 795 | 714 | $64K |
| 80053 | Comprehensive metabolic panel | 1.6% | 13,106 | 10,725 | $62K |
58 more codes
| 86710 | 1.5% | 2,021 | $56K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.3% | 1,100 | $52K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 1,300 | $46K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 380 | $32K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 510 | $22K |
| 84484 | <1% | 2,060 | $21K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 304 | $19K |
| 81000 | <1% | 7,159 | $18K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 317 | $17K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 470 | $15K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,268 | $13K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 515 | $13K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 76 | $8K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 245 | $7K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 589 | $6K |
| 83690 | <1% | 925 | $6K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 90 | $5K |
| 81025 | <1% | 1,022 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 74 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 70 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 30 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,253 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 53 | $3K |
| 83735 | <1% | 661 | $2K | |
| 86171 | <1% | 139 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 29 | $2K |
| 82150 | <1% | 228 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 71 | $982.96 |
| 76801 | <1% | 17 | $856.80 | |
| 83605 | <1% | 116 | $824.55 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 13 | $786.01 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 165 | $602.70 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 29 | $542.50 |
| 87088 | <1% | 68 | $461.59 | |
| 87040 | <1% | 17 | $348.25 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 18 | $301.20 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,103 | $261.47 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,457 | $250.46 |
| 82962 | <1% | 34 | $244.39 | |
| 85610 | <1% | 87 | $230.14 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 59 | $219.16 |
| 85730 | <1% | 42 | $182.68 | |
| 73562 | <1% | 20 | $160.00 | |
| 87186 | <1% | 14 | $121.92 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 151 | $114.51 |
| 87077 | <1% | 14 | $72.82 | |
| 85018 | <1% | 17 | $69.58 | |
| 84100 | <1% | 47 | $64.93 | |
| 83519 | <1% | 16 | $48.20 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 281 | $43.60 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 356 | $41.16 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $39.54 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 27 | $36.92 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 119 | $21.82 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 12 | $12.78 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 12 | $1.56 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 238 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 357 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.